Evidence map›Paper›PMID 36080409›Full record

ArticleMolecules (Basel, Switzerland)2022

Synthesis of thia-Michael-Type Adducts between Naphthoquinones and

Gabriele Micheletti, Carla Boga, Chiara Zalambani, Giovanna Farruggia, Erika Esposito, Jessica Fiori, Nicola Rizzardi, Paola Taddei, Michele Di Foggia, Natalia Calonghi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gabriele MichelettiDepartment of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Università di Bologna, Viale Del Risorgimento 4, 40136 Bologna, Italy.ORCID 0000-0001-9746-2356
Carla BogaDepartment of Industrial Chemistry 'Toso Montanari', Alma Mater Studiorum-Università di Bologna, Viale Del Risorgimento 4, 40136 Bologna, Italy.ORCID 0000-0003-2851-8939
Chiara ZalambaniDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
Giovanna FarruggiaDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0003-3599-7034
Erika EspositoDepartment of Chemistry 'G. Ciamician', Alma Mater Studiorum-Università di Bologna, Via Selmi 2, 40126 Bologna, Italy.
Jessica FioriDepartment of Chemistry 'G. Ciamician', Alma Mater Studiorum-Università di Bologna, Via Selmi 2, 40126 Bologna, Italy.
Nicola RizzardiDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-9294-7116
Paola TaddeiDepartment of Biomedical and Neuromotor Sciences, Alma Mater Studiorum-Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0001-8478-4508
Michele Di FoggiaDepartment of Biomedical and Neuromotor Sciences, Alma Mater Studiorum-Università di Bologna, Via Irnerio 48, 40126 Bologna, Italy.ORCID 0000-0002-0591-0105
Natalia CalonghiDepartment of Pharmacy and Biotechnology, University of Bologna, 40126 Bologna, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of naphthoquinones, namely, 1,4-naphthoquinone, menadione, plumbagin, juglone, naphthazarin, and lawsone, were reacted with

Indexed as

NaphthoquinonesNeuroblastomaAcetylcysteineCell Line, TumorHeLa CellsHumansReactive Oxygen SpeciesAcetylcysteineNaphthoquinonesReactive Oxygen SpeciescancerjuglonemenadioneN-acetyl-L-cysteinenaphthazarinnaphthoquinoneplumbaginthia-Michael

Identifiers

PMID36080409
PMCPMC9457610
OpenAlexW4294176610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.